The close relationship between FAT4 and the JAK-STAT signaling pathway has been well established [19], and SOCS1, a known key player of JAK-STAT pathway, was previously identified as a favorable prognostic biomarker in DLBCL [20, 21]. This evidence concerns the gene FAT4 and diffuse large B-cell lymphoma.